autoimmune disease and semaglutide GLP-1 Drugs Lower Risk of Death by 44% in Obesity Do Anti-Obesity Medications Benefit Autoimmune

Today, several GLP-1 RAs are available in the market

References InfantRisk Center

Making small lifestyle changes can help support your digestive health, reduce constipation, and keep you feeling comfortable

Providers operating within defined clinical parameters are increasingly recognized as essential in the GLP-1 treatment landscape, where medication efficacy depends on appropriate administration and follow-up

Notably, nearly 50% of the retatrutide phase 2 obesity trial were men, which is higher than in phase 3 clinical trials with tirzepatide (32.5% in SURMOUNT-1 [27]) and semaglutide 2.4 mg (25.9% in STEP-1 [8])

But when combined with B12, it can slightly alter the overall hue, potentially pushing the pink toward a slightly warmer or more salmon-like tone